FGF19/FGFR4 signaling contributes to hepatocellular carcinoma survival and immune escape by regulating IGF2BP1-mediated expression of PD-L1-Reference-Cited by-同舟云学术

FGF19/FGFR4 signaling contributes to hepatocellular carcinoma survival and immune escape by regulating IGF2BP1-mediated expression of PD-L1

Published:2024-01 Issue: Volume:170 Page:115955
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Guo Chaoqin^ORCID,Zhou Nana,Lu Yisong,Mu Mingshan,Li Zilin,Zhang Xu,Tu Linglan^ORCID,Du Jingyang,Li Xiangyu,Huang Dongsheng,Xu Qiuran^ORCID,Zheng Xiaoliang^ORCID

Funder

Natural Science Foundation of Zhejiang Province

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference33 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

2. Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca(2+)/PI3K/AKT pathway;Dou;Oncogene,2019

3. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial;El-Khoueiry;Lancet,2017

4. K.-. investigators, Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial;Zhu;Lancet Oncol.,2018

5. Combination strategies with PD-1/PD-L1 blockade: current advances and future directions;Yi;Mol. Cancer,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PPP1R14B-mediated phosphorylation enhances protein stability of RPS6KA1 to promote hepatocellular carcinoma tumorigenesis;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-12

2. USP24 promotes hepatocellular carcinoma tumorigenesis through deubiquitinating and stabilizing TRAF2;Biochemical Pharmacology;2024-11

3. The role of RNA methylation in tumor immunity and its potential in immunotherapy;Molecular Cancer;2024-06-20